Y-Intercept (HK)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,229
Closed -$500K 1458
2024
Q4
$500K Sell
9,229
-11,096
-55% -$601K 0.03% 726
2024
Q3
$1.02M Buy
20,325
+7,247
+55% +$365K 0.06% 440
2024
Q2
$575K Buy
+13,078
New +$575K 0.03% 750
2024
Q1
Sell
-11,227
Closed -$678K 1611
2023
Q4
$678K Buy
+11,227
New +$678K 0.06% 468